BDMAI

Infinite Right-to-Left Scrolling Marquee
Latest Circulars

Sectoral Plan for Effective Logistics – Pharma Sector

BDMAI News Letter – Material contribution by Members

Interaction with USP, India team with our Member companies on 9.1.2025 at 2.00 p.m.

Pharma MSME Industry Meet – 24.1.2025

Delays in obtaining URN / Permission for Destruction of Controlled Substances from NCB

MOU Signing Ceremony between BDMAI and Telangana Council of Higher Education

Implementation of Schedule M – Online Demo by CDSCO for filling application on 14th February 2025

Allotment of land in Green Pharma City, Telangana

Launch of a Scheme for Promotion of Research & Innovation in Pharma MedTech (PRIP) Sector by Department of Pharmaceuticals, Govt. of India

New Guidelines for obtaining NoC for Export of Unapproved/Approved New Drugs

Free In-House Up-Skilling Programme by LSSSDC for Employees BDMAI Member companies

ICH Guidelines- Q7- Telugu Translated version

Special offer by Avila International – Travel Package – CPhI China

Online Application for implementation of Schedule M

Sectoral Plan for Effective Logistics – Pharma Sector

BDMAI News Letter – Material contribution by Members

Interaction with USP, India team with our Member companies on 9.1.2025 at 2.00 p.m.

Pharma MSME Industry Meet – 24.1.2025

Delays in obtaining URN / Permission for Destruction of Controlled Substances from NCB

MOU Signing Ceremony between BDMAI and Telangana Council of Higher Education

Implementation of Schedule M – Online Demo by CDSCO for filling application on 14th February 2025

Allotment of land in Green Pharma City, Telangana

Launch of a Scheme for Promotion of Research & Innovation in Pharma MedTech (PRIP) Sector by Department of Pharmaceuticals, Govt. of India

New Guidelines for obtaining NoC for Export of Unapproved/Approved New Drugs

Free In-House Up-Skilling Programme by LSSSDC for Employees BDMAI Member companies

ICH Guidelines- Q7- Telugu Translated version

Special offer by Avila International – Travel Package – CPhI China

Online Application for implementation of Schedule M

Role of BDMA

The association aims to provide a platform for discussions among member industries on key issues affecting the Bulk Drug sector, including national, technical, economic, and commercial policies. By facilitating dialogue, it helps in formulating collective industry views to ensure that members’ concerns are effectively represented.

Fostering collaboration and mutual support among members is another key objective. By encouraging cooperation, the association creates a strong network that can collectively address challenges, share best practices, and drive industry progress.

Advocacy is a crucial function, as the association represents its members’ interests in legislative and regulatory matters at both state and central levels. It works to influence policies that support the sustainable growth of the Bulk Drug sector, ensuring that industry perspectives are considered in decision-making.

Additionally, the association disseminates vital industry-related information through publications, reports, and circulars. This helps members stay informed about regulatory updates, market trends, and technological advancements, allowing them to remain competitive in a rapidly evolving industry.

Promoting research and innovation is another priority. The association encourages the development of new technologies and supports the discovery of beneficial inventions that enhance efficiency and global competitiveness in Bulk Drug manufacturing.

Lastly, it is committed to developing strategies to strengthen both domestic and export markets for Indian-manufactured Bulk Drugs. By identifying growth opportunities and addressing trade challenges, the association helps position India as a key player in the global pharmaceutical market.

© 2021 Templately copyright all right reserved